Outlook Therapeutics (OTLK) Change in Cash: 2015-2020
Historic Change in Cash for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$11.4 million.
- Outlook Therapeutics' Change in Cash fell 89.93% to -$11.4 million in Q3 2020 from the same period last year, while for Sep 2020 it was $4.5 million, marking a year-over-year decrease of 28.23%. This contributed to the annual value of -$8.5 million for FY2024, which is 241.19% down from last year.
- Latest data reveals that Outlook Therapeutics reported Change in Cash of -$11.4 million as of Q3 2020, which was down 159.16% from $19.3 million recorded in Q2 2020.
- Outlook Therapeutics' 5-year Change in Cash high stood at $19.3 million for Q2 2020, and its period low was -$11.4 million during Q3 2020.
- Its 3-year average for Change in Cash is -$118,345, with a median of -$1.5 million in 2018.
- Within the past 5 years, the most significant YoY rise in Outlook Therapeutics' Change in Cash was 9,858.63% (2018), while the steepest drop was 430.94% (2018).
- Quarterly analysis of 5 years shows Outlook Therapeutics' Change in Cash stood at -$273,352 in 2016, then skyrocketed by 3,996.90% to $10.7 million in 2017, then slumped by 113.98% to -$1.5 million in 2018, then crashed by 348.55% to -$6.7 million in 2019, then slumped by 89.93% to -$11.4 million in 2020.
- Its Change in Cash was -$11.4 million in Q3 2020, compared to $19.3 million in Q2 2020 and $3.3 million in Q1 2020.